Navigation Links
China Shenghuo Announces Additional Roll-Out of '12 Ways' Cosmetics Products to Watsons Stores

KUNMING, China, Dec. 9 /PRNewswire-Asia-FirstCall/ -- China Shenghuo Pharmaceutical Holdings, Inc. (NYSE Alternext US: KUN) ("China Shenghuo" or the "Company"), today announced that the Company is expanding its herbal-based "12 Ways" cosmetics products into additional Watsons Personal Stores in strategic markets in Mainland China.

The Company has already launched its "12 Ways" brand of cosmetics products to eleven stores of the Watsons Your Personal Store ("Watsons Stores") in seven cities in China. Watsons Stores is the largest health and beauty retailer in China and Asia. By the end of December, the Company expects to enter an additional eleven Watsons stores in eight different cities including Shenzhen and Guangzhou. Furthermore, the Company is planning to add an additional eleven stores by early 2009 to include cities such as Shanghai and Kunming.

"Watsons Stores is an excellent entry point for China Shenghuo to introduce our high-end '12 Ways' cosmetics products," Mr. Gui Hua Lan, Chief Executive Officer of China Shenghuo, said. "We believe our partnership with Watsons and our anticipated success will give us a greater marketing platform to continue our expansion into other markets."

"12 Ways" cosmetics contain natural ingredients including herbal anti- irritants and anti-oxidants as well as Sanchi, which is the key ingredient for the Company's pharmaceutical products. Introduced in September of 2007, "12 Ways" is the Company's Sanchi-based cosmetics product lines that feature products varying from eye, face and skin creams to shampoos. The Company has already launched a total of 37 different cosmetics products for sale. The "12 Ways" products that are being rolled out to Watsons include Panax Notoginseng Moisture Series, Danshen Spots Fade Series, Yunnan Bamboo Anti-Acne Series, Snow Poria Whitening Series, Sunscreen Series and Eye Care Series.

About Watsons Your Personal Store

Watsons Your Personal Store ("Watsons Stores") is one of the largest health and beauty retail chains in Asia. Currently, Watsons Stores operates in thirteen different markets include Hong Kong, Mainland China, Taiwan, Singapore, Malaysia, Thailand, Indonesia, Macau, Korea, the Philippines, Turkey, Estonia and Slovenia and offers more than 25,000 products in over 1,600 outlets. For additional detail regarding Watsons and its corporate parent A.S. Watson Group, please see .

About China Shenghuo

Founded in 1995, China Shenghuo is a specialty pharmaceutical company that focuses on the research, development, manufacture and marketing of Sanchi- based medicinal and pharmaceutical, nutritional supplement and cosmetic products. Through its subsidiary, Kunming Shenghuo Pharmaceutical (Group) Co., Ltd., it owns thirty SFDA (State Food and Drug Administration) approved medicines, including the flagship product Xuesaitong Soft Capsules, which has already been listed in the Insurance Catalogue. At present, China Shenghuo incorporates a sales network of agencies and representatives throughout China, which markets Sanchi-based traditional Chinese medicine to hospitals and drug stores as prescription and OTC drugs primarily for the treatment of cardiovascular, cerebrovascular and peptic ulcer disease. The Company also exports medicinal products to Asian countries such as Indonesia, Russia and Kyrgyzstan. For more information, please visit .

Safe Harbor Statement

This press release may contain certain "forward-looking statements," as defined in the United States Private Securities Litigation Reform Act of 1995, that involve a number of risks and uncertainties. There can be no assurance that such statements will prove to be accurate, and the actual results and future events could differ materially from management's current expectations. Such factors include, but are not limited to, risks of litigation and governmental or other regulatory inquiry or proceedings arising out of or related to any of the matters described in recent press releases, including arising out of the restatement of the Company's financial statements; the Company's continuing ability to satisfy any requirements which may be prescribed by the Exchange for continued listing on the Exchange; potential adverse effects to the Company's financial condition, results of operations or prospects as a result of possible changes to or restatements of prior period financial statements; risks arising from potential weaknesses or deficiencies in the Company's internal control over financial reporting; the Company's reliance on one supplier for Sanchi; the possible effect of adverse publicity on the Company's business, including possible contract cancellation; the Company's ability to develop and market new products; the Company's ability to establish and maintain a strong brand; the Company's continued ability to obtain and maintain all certificates, permits and licenses required to open and operate retail specialty counters to offer its cosmetic products and conduct business in China; protection of the Company's intellectual property rights; market acceptance of the Company's products; changes in the laws of the People's Republic of China that affect the Company's operations; cost to the Company of complying with current and future governmental regulations; the impact of any changes in governmental regulations on the Company's operations; general economic conditions; and other factors detailed from time to time in the Company's filings with the United States Securities and Exchange Commission and other regulatory authorities. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

    For more information, please contact:

    China Shenghuo Pharmaceutical Holdings, Inc.
     Mr. Changhua Mu
     Securities Affairs Representative
     Tel:   +86-871-728-2698

    Grayling Global
     Eddie Cheung
     Investor Relations
     Tel:   +1-646-284-9414

SOURCE China Shenghuo Pharmaceutical Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. China Sky One Medical, Inc. Obtains Production Rights for Two New Drugs
2. Greater China suppliers set to end tough 2008 with strong buyer activity at Global Sources Private Sourcing Events
3. Diagnosis and Drug Treatment of Alzheimers Disease in China is Low and Will Remain Low Through 2012
4. China Sky One Medical, Inc. Appoints Yu-bo Hao as CFO
5. Applied Biosystems – Part of Life Technologies – Helps China Respond to Melamine Contamination in Dairy Products : Government and Industry Increase Contaminant Testing to Increase Food Safety
6. CCID Consulting Discusses Chinas Medical Equipment Market
7. China West II Files Suit Against Genesis Pharmaceuticals and Capital Research Group Inc, Announces Conference Call Details
8. China Nepstar Chain Drugstore Reports Third Quarter 2008 Results
9. China Shenghuo Announces Restated Results For Full Year 2007 & First Quarter 2008, Reports Results For Second & Third Quarter 2008
10. ChinaBio(R) Inaugural Partnering Forum Scheduled for June 2009 in Shanghai, China
11. China Documents First Case of Tick-Borne Disease Spread
Post Your Comments:
(Date:6/27/2016)... ... 27, 2016 , ... TherapySites, the leading website ... Tennessee Counseling Association. This new relationship allows TherapySites to continue to ... adding exclusive benefits and promotional offers. , "TCA is extremely excited about this ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... recently ... of Eyeglasses . , Millions of individuals in the United States and Canada ... become a way to both correct vision and make a fashion statement. Even celebrities ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media ... give their videos a whole new perspective by using the title layers in ... Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... have been diagnosed with endometriosis. These women need a treatment plan to not ... comprehensive approach that can help for preservation of fertility and ultimately achieving a ...
(Date:6/25/2016)... , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on ... Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ability ... fumigation is not a common occurrence, but a necessary one in the event that lice ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
(Date:6/23/2016)... , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with ... Latin America . ... ... ... ...
(Date:6/23/2016)... 2016 The vast majority of dialysis patients ... Treatments are usually 3 times a week, with treatment ... travel time, equipment preparation and wait time.  This regimen ... for patients who are elderly and frail.  Many elderly ... rehabilitation centers for some duration of time. ...
Breaking Medicine Technology: